Surmodics Revenue 2010-2025 | SRDX

Surmodics revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Surmodics Annual Revenue
(Millions of US $)
2024 $126
2023 $133
2022 $100
2021 $105
2020 $95
2019 $100
2018 $81
2017 $73
2016 $71
2015 $62
2014 $57
2013 $56
2012 $52
2011 $53
2010 $54
2009 $122
Surmodics Quarterly Revenue
(Millions of US $)
2025-03-31 $28
2024-12-31 $30
2024-09-30 $33
2024-06-30 $30
2024-03-31 $32
2023-12-31 $31
2023-09-30 $28
2023-06-30 $52
2023-03-31 $27
2022-12-31 $25
2022-09-30 $26
2022-06-30 $25
2022-03-31 $26
2021-12-31 $23
2021-09-30 $24
2021-06-30 $24
2021-03-31 $35
2020-12-31 $22
2020-09-30 $23
2020-06-30 $27
2020-03-31 $23
2019-12-31 $23
2019-09-30 $31
2019-06-30 $24
2019-03-31 $23
2018-12-31 $22
2018-09-30 $23
2018-06-30 $22
2018-03-31 $19
2017-12-31 $17
2017-09-30 $20
2017-06-30 $18
2017-03-31 $18
2016-12-31 $18
2016-09-30 $18
2016-06-30 $20
2016-03-31 $17
2015-12-31 $17
2015-09-30 $17
2015-06-30 $16
2015-03-31 $14
2014-12-31 $14
2014-09-30 $15
2014-06-30 $15
2014-03-31 $14
2013-12-31 $14
2013-09-30 $14
2013-06-30 $14
2013-03-31 $14
2012-12-31 $14
2012-09-30 $14
2012-06-30 $14
2012-03-31 $12
2011-12-31 $12
2011-09-30 $14
2011-06-30 $13
2011-03-31 $13
2010-12-31 $13
2010-09-30 $16
2010-06-30 $19
2010-03-31 $18
2009-12-31 $17
2009-09-30 $19
2009-06-30 $18
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.444B $0.126B
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.442B 27.95
Boston Scientific (BSX) United States $153.655B 38.47
Stryker (SYK) United States $150.679B 31.51
EssilorLuxottica (ESLOY) France $135.238B 0.00
Medtronic (MDT) Ireland $114.659B 16.25
Lonza Group Ag (LZAGY) Switzerland $51.418B 0.00
Haleon (HLN) United Kingdom $45.416B 25.92
ResMed (RMD) United States $37.840B 28.42
Agilent Technologies (A) United States $35.272B 22.99
GE HealthCare Technologies (GEHC) United States $35.028B 16.63
Terumo (TRUMY) Japan $24.711B 32.10
Koninklijke Philips (PHG) Netherlands $23.746B 16.66
Insulet (PODD) United States $20.930B 82.15
Zimmer Biomet Holdings (ZBH) United States $18.825B 12.09
Baxter (BAX) United States $15.241B 11.38
Smith & Nephew SNATS (SNN) United Kingdom $13.608B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $7.072B 24.61
Lantheus Holdings (LNTH) United States $5.800B 14.63
Prestige Consumer Healthcare (PBH) United States $3.832B 17.12
Haemonetics (HAE) United States $3.755B 17.10
Perrigo (PRGO) Ireland $3.749B 9.50
Envista Holdings (NVST) United States $3.512B 29.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.378B 24.91
QuidelOrtho (QDEL) United States $2.134B 14.67
LeMaitre Vascular (LMAT) United States $1.937B 43.31
AtriCure (ATRC) United States $1.587B 0.00
Acuren (TIC) United States $1.427B 0.00
Green Thumb Industries (GTBIF) United States $1.357B 30.52
AdaptHealth (AHCO) United States $1.275B 12.94
Phibro Animal Health (PAHC) United States $1.262B 16.14
Neogen (NEOG) United States $1.211B 15.50
BioLife Solutions (BLFS) United States $1.087B 0.00
InMode (INMD) Israel $0.960B 9.67
Curaleaf Holdings (CURLF) Canada $0.818B 0.00
Kestra Medical Technologies (KMTS) United States $0.780B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.736B 0.00
Tilray Brands (TLRY) Canada $0.641B 0.00
Owens & Minor (OMI) United States $0.640B 5.31
Evolus (EOLS) United States $0.627B 0.00
CeriBell (CBLL) United States $0.606B 0.00
Capricor Therapeutics (CAPR) United States $0.521B 0.00
Valneva SE (VALN) France $0.511B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.352B 12.94
Cresco Labs (CRLBF) United States $0.342B 0.00
Sanuwave Health (SNWV) United States $0.307B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Cerus (CERS) United States $0.296B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.273B 0.00
Aurora Cannabis (ACB) Canada $0.264B 78.17
ZimVie (ZIMV) United States $0.262B 11.90
Brainsway (BWAY) Israel $0.239B 63.17
Biote (BTMD) United States $0.230B 6.48
OraSure Technologies (OSUR) United States $0.228B 0.00
Verano Holdings (VRNOF) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.219B 0.00
Omeros (OMER) United States $0.203B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.194B 0.00
TriSalus Life Sciences (TLSI) United States $0.189B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.14
Vireo Growth (VREOF) United States $0.164B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.124B 15.25
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.100B 12.91
MacroGenics (MGNX) United States $0.100B 0.00
Jushi Holdings (JUSHF) United States $0.098B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.085B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
InterCure (INCR) Israel $0.073B 0.00
Cytosorbents (CTSO) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
Zynex (ZYXI) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.57
United-Guardian (UG) United States $0.038B 13.02
Safety Shot (SHOT) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00